Molecular profiling of HNSCC patient samples has identified BRCA1 and BRCA2 mutations with a frequency of 5.75% and 9.2%, respectively, which seem to co-exist with TP53 and PI3KCA pathway mutations [141]. This evidence concerns the gene BRCA1 and head and neck squamous cell carcinoma.